期刊文献+

The role of post-translational modifications of huntingtin in the pathogenesis of Huntington's disease

亨廷顿蛋白的翻译后修饰在亨廷顿病发病机制中的作用(英文)
原文传递
导出
摘要 Post-translational modifications are rapid, effective and reversible ways to regulate protein stability, localization, function, and their interactions with other molecules. Post-translational modifications usually occur as chemical modifications at amino acid residues, including SUMOylation, phosphorylation, palmitoylation, acetylation, etc. These complex biochemical modifications tightly regulate and control a variety of cellular processes. Several forms of post-translational modifications of huntingtin (Htt) have been described. These modifications affect Htt metabolism, protein-protein interactions and cellular toxicity. Cleavage and clearance of mutant Htt, and the interactions between mutant Htt and other cellular proteins are important biochemical events leading to Huntington's disease (HD). Therefore, identifying signaling pathways of Htt modification and evaluating the significance of Htt modifications would lead to a better understanding of the normal function of wild-type Htt and the pathogenic mechanisms of mutant Htt. 翻译后修饰能快速、有效且可逆地调节蛋白的稳定性、分布位置、功能及其与其它分子之间的相互作用。翻译后修饰主要包括氨基酸残基的SUMO化、磷酸化、棕榈化以及乙酰化等。这些复杂的生化修饰能严格、规范地调节各种细胞过程。亨廷顿蛋白(Htt)的几种翻译后修饰方式已见报道。这些翻译后修饰会影响Htt的代谢、Htt与其它蛋白质的相互作用以及Htt的细胞毒性。突变Htt的剪切、清除以及与其它细胞蛋白质的相互作用是导致亨廷顿病的重要生化事件。因此,了解Htt修饰的信号转导及其意义,可以帮助我们更好地理解野生型Htt的正常功能和突变Htt的致病机制。
出处 《Neuroscience Bulletin》 SCIE CAS CSCD 2010年第2期153-162,共10页 神经科学通报(英文版)
基金 supported by grants from the National Natural Science Foundation of China (No.30600197)
关键词 Huntington's disease HUNTINGTIN modification SUMOYLATION PHOSPHORYLATION PALMITOYLATION ACETYLATION 亨廷顿病 亨廷顿蛋白 修饰 SUMO化 磷酸化 棕榈酰化 乙酰化
  • 相关文献

参考文献66

  • 1Steffan JS, Agrawal N, Pallos J, Rockabrand E, Trotman LC, Slepko N, et al. SUMO modification of Huntingtin and Huntington's disease pathology. Science 2004, 304 (5667): 100- 104.
  • 2Wellington CL, Singaraja R, Ellerby L, Savill J, Roy S, Leavitt B, et al. Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J Biol Chem 2000, 275 (26): 19831-19838.
  • 3DiFiglia M, Sapp E, Chase KO, Davies SW, Bates GP, Vonsattel JP, et al. Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 1997, 277 (5334): 1990-1993.
  • 4Kegel KB, Sapp E, Yoder J, Cuiffo B, Sobin L, Kim YJ, et al. Huntingtin associates with acidic phospholipids at the plasma membrane. J Biol Cbem 2005, 280 (43): 36464-36473.
  • 5Humbert S, Bryson EA, Cordelieres FP, Connors NC, Datta SR, Finkbeiner S, et al. The IGF-1/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt. Dev Cell 2002, 2 (6): 831-837.
  • 6Warby SC, Chan EY, Metzler M, Gan L, Singaraja RR, Crocker SF, et al. Huntingtin phosphorylation on serine 421 is significantly reduced in the striatum and by polyglutamine expansion in vivo. Hum Mol Genet 2005, 14 (11): 1569-1577.
  • 7Dorval V, Fraser PE. SUMO on the road to neurodegeneration. Biochim Biophys Acta 2007, 1773 (6): 694-706.
  • 8Dohmen RJ. SUMO protein modification. Biochim Biophys Acta 2004, 1695 (1-3): 113-131.
  • 9Su HL, Li SS. Molecular features of human ubiquitin-like SUMO genes and their encoded proteins. Gene 2002, 296 (1-2): 65-73.
  • 10Hay RT. SUMO: a history of modification. Mol Cell 2005, 18(1): 1-12.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部